Last reviewed · How we verify

NCT04725019

Enhancing Motor Learning in Children With Cerebral Palsy Using Transcranial Direct-current Stimulation

Not yet recruiting NA Last updated 26 January 2021
What this trial tests

NA trial testing active transcranial direct current stimulation in Cerebral Palsy in 60 participants. Not yet recruiting.

Timeline
1 August 2021
Primary endpoint
31 July 2026
31 July 2026

Quick facts

Lead sponsorBoston University Charles River Campus
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date1 August 2021
Primary completion31 July 2026
Estimated completion31 July 2026

Drugs / interventions tested

Conditions studied

Sponsor

Boston University Charles River Campus

Who can join

Adults 6 to 17, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to test the effects of transcranial direct current stimulation (tDCS) on motor learning and brain plasticity in children with unilateral spastic cerebral palsy (USCP).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. sPinal cOrd neUromodulatioN to treat Cerebral palsy in pEdiatrics: POUNCE Multisite Randomized Clinical Trial.
    Girshin K, Sachdeva R, Cohn R, Gad P, et al · · 2023 · cited 2× · PMID 37564370 · DOI 10.3389/fnins.2023.1221809

Verify or expand the search:

Other trials of active transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Boston University Charles River Campus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04725019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing